Kyttaro Therapeutics
Biotechnology Research
4 employees
- Employees
- 4
- Contacts
- 1
- Emails
- 1
- Phones
- 1
Kyttaro Therapeutics Overview
- Website
- kyttarotherapeutics.com
- Industry
- Biotechnology Research
- Employees
- 4
- Founded
- 2021
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Kyttaro Therapeutics
Kyttaro Therapeutics was incorporated in the US in 2021 to commercialize technologies developed by the founders of Apceth Biopharma GmbH since 2007. The company is headquartered in New York, with research operations in Germany. Kyttaro Therapeutics is a development-stage platform technology company with a unique patent portfolio in clinical applications of mesenchymal stem cells (MSCs) for treatment of diseases with a high, unmet clinical need. Kyttaro’s expertise and intellectual property are based on 15 years of research and development in Germany and around the world in cutting-edge applications for MSC Alpha-1 Antitrypsin (MSC-AAT), MSC Cytokines (MSC-Cyt) and MSC-Klotho.
Kyttaro Therapeutics Contact Details
- People in AeroLeads
- 2
- With contact data
- 1
- Email contacts
- 1
- 50.0% coverage
- Phone contacts
- 1
- 50.0% coverage
Kyttaro Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Manfred Stangl | Co-founder and Cso Kyttaro Therapeutics | Hohenbrunn, Bavaria, Germany |
View
|
| Leanne Larson | Senior Vice President and Managing | Wilmette, Illinois, United States |
Email
Phone
|
Compare Similar Companies to Kyttaro Therapeutics
Made Scientific
Pharmaceutical Manufacturing
BioMixing S.L.
Biotechnology Research
Persephoni BIO
Venture Capital And Private Equity Principals
Genesis BioCapital
Venture Capital And Private Equity Principals
MICREGEN LTD
Biotechnology Research
Cobiomic Bioscience SL
Research Services
Tiaris Biosciences SL
Biotechnology Research
Leucadia Therapeutics
Biotechnology
KOMO Biosciences
Biotechnology Research
SMART Bio Works LLC
Business Consulting And Services